All News

In October, we celebrate American Pharmacists Month.

Have you ever considered pursuing a PGY-2 pharmacy residency in psychiatry?

A 3-step process to compare pharmacy schools' prerequisites and set an application timeline.

Imagine you are blind. How do you tell one prescription bottle from the next?

It is currently the first and only extended-release, intra-articular injection available for OA.

The study found patients who were prescribed antibiotics for dental procedures tended to be older and more likely to receive clindamycin, an antibiotic that is associated with C diff infection.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at the top stories in pharmacy last week.

Employers may have the market power to demand transparency from pharmacy benefit managers.

Mastectomy rates increased after actress Angelia Jolie announced her procedure.

Top news from across the healthcare landscape.

Top news from across the healthcare landscape.

FDA officials have approved an 80-mg capsule strength of Neurocrine Biosciences’ valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia (TD), the company announced in a press release

Janssen is seeking FDA approval for its once-daily darunavir-based regimen for HIV.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the week from Specialty Pharmacy Times.

National brand spending and new patient rates for hepatitis C virus dropped last year.

FDA officials have approved the first test for screening Zika virus in blood donations.

Qualitative nucleic acid test is designed to detect Zika virus RNA in individual donor plasma specimens.

Spending for adalimumab has tripled from 2012 from $4.5 billion.

Pharmacists who are unfamiliar with either the principles of infectious disease or HIV may miss errors.

Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.

The National Community Pharmacists Association (NCPA) shared with Congress eight recommendations for leveraging independent community pharmacists' knowledge and proximity to patients to help address the opioid crisis.

A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.

Oral vitamin D supplementation, in addition to asthma medications, could reduce the risk of asthma attacks requiring hospital attendance by 50%, according to a recently-published study in The Lancet of Respiratory Medicine.

Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.

Payers and manufacturers look for specialty pharmacy partners with several key aspects.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

The Express Scripts Medicare Value and Choice plans cover up to 75% of costs after the deductible for specialty drugs.